- Home
- ICCM vs GAN Comparison
ICCM vs GAN Comparison
Compare ICCM & GAN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ICCM
- GAN
- Stock Information
- Founded
- ICCM 2006
- GAN 1999
- Country
- ICCM Israel
- GAN United States
- Employees
- ICCM N/A
- GAN N/A
- Industry
- ICCM
- GAN Computer Software: Programming Data Processing
- Sector
- ICCM
- GAN Technology
- Exchange
- ICCM Nasdaq
- GAN Nasdaq
- Market Cap
- ICCM 72.4M
- GAN 83.2M
- IPO Year
- ICCM N/A
- GAN 2020
- Fundamental
- Price
- ICCM $1.21
- GAN $1.88
- Analyst Decision
- ICCM Strong Buy
- GAN
- Analyst Count
- ICCM 2
- GAN 0
- Target Price
- ICCM $2.70
- GAN N/A
- AVG Volume (30 Days)
- ICCM 441.2K
- GAN 218.4K
- Earning Date
- ICCM 11-26-2024
- GAN 03-12-2025
- Dividend Yield
- ICCM N/A
- GAN N/A
- EPS Growth
- ICCM N/A
- GAN N/A
- EPS
- ICCM N/A
- GAN N/A
- Revenue
- ICCM $3,671,000.00
- GAN $134,024,000.00
- Revenue This Year
- ICCM $10.03
- GAN $5.97
- Revenue Next Year
- ICCM $62.68
- GAN $11.32
- P/E Ratio
- ICCM N/A
- GAN N/A
- Revenue Growth
- ICCM 26.02
- GAN N/A
- 52 Week Low
- ICCM $0.48
- GAN $1.17
- 52 Week High
- ICCM $1.57
- GAN $1.88
- Technical
- Relative Strength Index (RSI)
- ICCM 60.15
- GAN 56.91
- Support Level
- ICCM $1.16
- GAN $1.84
- Resistance Level
- ICCM $1.27
- GAN $1.88
- Average True Range (ATR)
- ICCM 0.10
- GAN 0.03
- MACD
- ICCM -0.02
- GAN 0.00
- Stochastic Oscillator
- ICCM 41.64
- GAN 71.43
About ICCM IceCure Medical Ltd.
Icecure Medical Ltd is a commercial-stage medical device company. The company is engaged in the research, development, and marketing of cryoablation systems and technologies based on liquid nitrogen, or LN2, for treating tumors. Its cryoablation technology is a minimally invasive alternative to surgical intervention, for tumors, including those found in the breast, lungs, kidneys, bones, and other indications.
About GAN GAN Limited
GAN Ltd provides Software-as-a-Service solutions for online casino gaming and sports betting applications. The company has two operating segments B2B and B2C. The B2B segment develops, markets, and sells instances of GameSTACK, GAN Sports, and iSight Back Office technology that incorporates comprehensive player registration, account funding, and back-office accounting and management tools that enable the casino operators to efficiently, confidently, and effectively extend their presence online in places that have permitted online real money gaming, and The B2C segment, which includes the operations of Coolbet, develops and operates a B2C online sports betting and casino platform that is accessible through its website in markets across Northern Europe, Latin America, and Canada.